Atovaquone and Proguanil HCl is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Pd-rx Pharmaceuticals, Inc.. The primary component is Atovaquone; Proguanil Hydrochloride.
| Product ID | 43063-522_7fc278b2-1478-6b90-e053-2a91aa0a55b3 |
| NDC | 43063-522 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Atovaquone and Proguanil HCl |
| Generic Name | Atovaquone And Proguanil Hydrochloride |
| Dosage Form | Tablet, Film Coated |
| Route of Administration | ORAL |
| Marketing Start Date | 2012-07-27 |
| Marketing Category | NDA AUTHORIZED GENERIC / NDA AUTHORIZED GENERIC |
| Application Number | NDA021078 |
| Labeler Name | PD-Rx Pharmaceuticals, Inc. |
| Substance Name | ATOVAQUONE; PROGUANIL HYDROCHLORIDE |
| Active Ingredient Strength | 250 mg/1; mg/1 |
| Pharm Classes | Antimalarial [EPC],Antiprotozoal [EPC],Antimalarial [EPC],Dihydrofolate Reductase Inhibitors [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
| Marketing Start Date | 2015-01-30 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA authorized generic |
| Application Number | NDA021078 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2015-01-30 |
| Marketing Category | NDA authorized generic |
| Application Number | NDA021078 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2015-01-30 |
| Marketing Category | NDA authorized generic |
| Application Number | NDA021078 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2015-01-30 |
| Marketing Category | NDA authorized generic |
| Application Number | NDA021078 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2015-01-30 |
| Marketing Category | NDA authorized generic |
| Application Number | NDA021078 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2015-01-30 |
| Marketing Category | NDA authorized generic |
| Application Number | NDA021078 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2015-01-30 |
| Marketing Category | NDA authorized generic |
| Application Number | NDA021078 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2015-01-30 |
| Ingredient | Strength |
|---|---|
| ATOVAQUONE | 250 mg/1 |
| SPL SET ID: | dcf43cbd-fc97-4dc1-a258-afad6cf4cabf |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 43063-522 | Atovaquone and Proguanil HCl | atovaquone and proguanil hydrochloride |
| 50090-2980 | Atovaquone and Proguanil HCl | atovaquone and proguanil hydrochloride |
| 63629-5531 | Atovaquone and Proguanil HCl | Atovaquone and Proguanil HCl |
| 66993-060 | Atovaquone and Proguanil HCl | Atovaquone and Proguanil HCl |
| 0378-4160 | Atovaquone and Proguanil Hydrochloride | atovaquone and proguanil hydrochloride |
| 0378-4162 | Atovaquone and Proguanil Hydrochloride | atovaquone and proguanil hydrochloride |
| 10544-909 | Atovaquone and Proguanil Hydrochloride | Atovaquone and Proguanil Hydrochloride |
| 33261-900 | Atovaquone and Proguanil Hydrochloride | Atovaquone and Proguanil Hydrochloride |
| 42254-150 | Atovaquone and Proguanil Hydrochloride | Atovaquone and Proguanil Hydrochloride |
| 43063-393 | Atovaquone and Proguanil Hydrochloride | Atovaquone and Proguanil Hydrochloride |
| 50090-1302 | Atovaquone and Proguanil Hydrochloride | Atovaquone and Proguanil Hydrochloride |
| 0173-0675 | MALARONE | atovaquone and proguanil hydrochloride |
| 0173-0676 | MALARONE | atovaquone and proguanil hydrochloride |
| 50090-0687 | MALARONE | atovaquone and proguanil hydrochloride |
| 50090-0688 | MALARONE | atovaquone and proguanil hydrochloride |